DE69427799T2 - Anthracycline konjugate, deren herstellung und deren verwendung als antitumorwirkstoffe - Google Patents

Anthracycline konjugate, deren herstellung und deren verwendung als antitumorwirkstoffe

Info

Publication number
DE69427799T2
DE69427799T2 DE69427799T DE69427799T DE69427799T2 DE 69427799 T2 DE69427799 T2 DE 69427799T2 DE 69427799 T DE69427799 T DE 69427799T DE 69427799 T DE69427799 T DE 69427799T DE 69427799 T2 DE69427799 T2 DE 69427799T2
Authority
DE
Germany
Prior art keywords
anthracycline
formula
polymer
gly
mol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69427799T
Other languages
German (de)
English (en)
Other versions
DE69427799D1 (de
Inventor
Francesco Angelucci
Maria Grandi
Antonino Suarato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Pharmacia and Upjohn SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn SpA filed Critical Pharmacia and Upjohn SpA
Application granted granted Critical
Publication of DE69427799D1 publication Critical patent/DE69427799D1/de
Publication of DE69427799T2 publication Critical patent/DE69427799T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyamides (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69427799T 1993-05-11 1994-04-08 Anthracycline konjugate, deren herstellung und deren verwendung als antitumorwirkstoffe Expired - Fee Related DE69427799T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939309663A GB9309663D0 (en) 1993-05-11 1993-05-11 Biologically active compounds
PCT/EP1994/001100 WO1994026311A1 (en) 1993-05-11 1994-04-08 Anthracycline conjugates, their preparation and their use as antitumor agents

Publications (2)

Publication Number Publication Date
DE69427799D1 DE69427799D1 (de) 2001-08-30
DE69427799T2 true DE69427799T2 (de) 2002-05-02

Family

ID=10735264

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69427799T Expired - Fee Related DE69427799T2 (de) 1993-05-11 1994-04-08 Anthracycline konjugate, deren herstellung und deren verwendung als antitumorwirkstoffe

Country Status (25)

Country Link
US (1) US5571785A (cg-RX-API-DMAC7.html)
EP (1) EP0649312B1 (cg-RX-API-DMAC7.html)
JP (1) JPH08502519A (cg-RX-API-DMAC7.html)
KR (1) KR100330635B1 (cg-RX-API-DMAC7.html)
CN (1) CN1098106C (cg-RX-API-DMAC7.html)
AT (1) ATE203414T1 (cg-RX-API-DMAC7.html)
AU (1) AU671741B2 (cg-RX-API-DMAC7.html)
CA (1) CA2136438C (cg-RX-API-DMAC7.html)
DE (1) DE69427799T2 (cg-RX-API-DMAC7.html)
DK (1) DK0649312T3 (cg-RX-API-DMAC7.html)
ES (1) ES2161764T3 (cg-RX-API-DMAC7.html)
FI (1) FI112602B (cg-RX-API-DMAC7.html)
GB (1) GB9309663D0 (cg-RX-API-DMAC7.html)
GR (1) GR3036978T3 (cg-RX-API-DMAC7.html)
HU (2) HUT70509A (cg-RX-API-DMAC7.html)
IL (1) IL109528A (cg-RX-API-DMAC7.html)
MY (1) MY110974A (cg-RX-API-DMAC7.html)
NZ (1) NZ265266A (cg-RX-API-DMAC7.html)
PL (1) PL175325B1 (cg-RX-API-DMAC7.html)
PT (1) PT649312E (cg-RX-API-DMAC7.html)
RU (1) RU2145965C1 (cg-RX-API-DMAC7.html)
TW (1) TW268015B (cg-RX-API-DMAC7.html)
UA (1) UA42695C2 (cg-RX-API-DMAC7.html)
WO (1) WO1994026311A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA943212B (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9320781D0 (en) * 1993-10-08 1993-12-01 Erba Carlo Spa Polymer-bound camptothecin derivatives
GB9721069D0 (en) 1997-10-03 1997-12-03 Pharmacia & Upjohn Spa Polymeric derivatives of camptothecin
GB9721070D0 (en) 1997-10-03 1997-12-03 Pharmacia & Upjohn Spa Bioactive derivatives of camptothecin
CA2445985A1 (en) * 2001-05-04 2002-11-14 University Of Utah Research Foundation Hyaluronic acid containing bioconjugates: targeted delivery of anti-cancer drugs to cancer cells
US7049285B2 (en) * 2001-10-31 2006-05-23 Myung-Ok Park Biocompatible polymers including peptide spacer
US20050169883A1 (en) * 2002-05-06 2005-08-04 Prestwich Glenn D. Preblocking with non-ha gags increases effectiveness of ha conjugated anticancer agents
WO2005004805A2 (en) * 2003-07-02 2005-01-20 Solux Corporation Thermally stable crystalline epirubicin hydrochloride and method of making the same
IL325256A (en) 2014-06-13 2026-02-01 Bach Biosciences Llc FAP-activated medical materials and related uses
WO2015192124A1 (en) * 2014-06-13 2015-12-17 Trustees Of Tufts College Fap-activated therapeutic agents, and uses related thereto

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5162512A (en) * 1982-03-09 1992-11-10 Cytogen Corporation Amine derivatives of anthracycline antibodies
JPS60246400A (ja) * 1984-05-22 1985-12-06 Ajinomoto Co Inc アントラサイクリン系化合物及び制ガン剤
GB8614323D0 (en) * 1986-06-12 1986-07-16 Erba Farmitalia Anthracyclines
US5169937A (en) * 1986-11-18 1992-12-08 The Scripps Research Institute Method for producing stable glycosylated hemoglobin
DE3722699A1 (de) * 1987-07-09 1989-01-19 Behringwerke Ag Zytostatisch wirksame anthacyclin-konjugate
CA2014244A1 (en) * 1989-04-13 1990-10-13 Takeda Chemical Industries, Ltd. Stabilized composition of anthracyclines
GB9017024D0 (en) * 1990-08-03 1990-09-19 Erba Carlo Spa New linker for bioactive agents
GB9026491D0 (en) * 1990-12-05 1991-01-23 Erba Carlo Spa Anthracycline-conjugates

Also Published As

Publication number Publication date
RU2145965C1 (ru) 2000-02-27
HU9403811D0 (en) 1995-03-28
PT649312E (pt) 2002-01-30
FI946128A7 (fi) 1994-12-28
CA2136438A1 (en) 1994-11-24
WO1994026311A1 (en) 1994-11-24
JPH08502519A (ja) 1996-03-19
NZ265266A (en) 1996-06-25
EP0649312B1 (en) 2001-07-25
GR3036978T3 (en) 2002-01-31
PL306861A1 (en) 1995-04-18
CN1098106C (zh) 2003-01-08
KR950702201A (ko) 1995-06-19
CA2136438C (en) 2004-09-14
ATE203414T1 (de) 2001-08-15
AU671741B2 (en) 1996-09-05
IL109528A (en) 1998-08-16
IL109528A0 (en) 1994-08-26
UA42695C2 (uk) 2001-11-15
KR100330635B1 (ko) 2002-09-17
DE69427799D1 (de) 2001-08-30
AU6566694A (en) 1994-12-12
ZA943212B (en) 1995-01-18
PL175325B1 (pl) 1998-12-31
HU211538A9 (en) 1995-12-28
EP0649312A1 (en) 1995-04-26
DK0649312T3 (da) 2001-11-12
TW268015B (cg-RX-API-DMAC7.html) 1996-01-11
FI946128A0 (fi) 1994-12-28
FI112602B (fi) 2003-12-31
CN1108454A (zh) 1995-09-13
MY110974A (en) 1999-07-31
RU94046336A (ru) 1996-10-27
HUT70509A (en) 1995-10-30
ES2161764T3 (es) 2001-12-16
GB9309663D0 (en) 1993-06-23
US5571785A (en) 1996-11-05

Similar Documents

Publication Publication Date Title
DE69432627T2 (de) Polymergebundene camptothecin-derivate
DE69821783T2 (de) Polymere verbindungen von camptothecin
DE69330776T2 (de) Polymergebundene Paclitaxel-derivate
EP0939765B1 (de) Glycokonjugate von modifizierten camptothecin-derivaten(a- oder b-ring-verknüpfung)
EP0934329B1 (de) Glycokonjugate von modifizierten camptothecin-derivaten (20-o-verknüpfung)
EP0981542B1 (de) Glycokonjugate von 20(s)-camptothecin
DE68910211T2 (de) Estramustin-ester.
EP0649312B1 (en) Anthracycline conjugates, their preparation and their use as antitumor agents
DE1811518C3 (de) Daunonibicinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE2945239A1 (de) Oligopeptide, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE69107431T2 (de) Deacetylcolchicinderivate.
DE69019771T2 (de) Pradimicinamidderivate.
AU777920B2 (en) Beta-D-5-thioxylose derivatives, preparation method and therapeutic use
EP1173454A1 (de) Verfahren zur herstellung von glycokonjugaten von 20(s)-camptothecin
WO2001058932A1 (de) Glycokonjugate von cytostatika
DE10005275A9 (de) Neuartige glycokonjugate
DE69405544T2 (de) 4'-0-sulfonylanthracyclinderivate
DE3301489C2 (cg-RX-API-DMAC7.html)
WO1998015573A1 (de) 20-o-verknüpfte glycokonjugate von camptothecin
DE2930637C2 (de) N-(L-Leucyl)-doxorubicin, Verfahren zu dessen Herstellung und dieses enthaltende pharmazeutische Zubereitungen
EP0422055A1 (en) Novel ursodeoxycholic acid derivative
CH693558A5 (de) Pharmazeutische Zusammensetzung.
DE3445646A1 (de) Neue aminglykoside, verfahren zu ihrer herstellung und ihre verwendung
DE19801037A1 (de) Glycokonjugate von 20(S)-Camptothecin
DE3306505A1 (de) Anthracyclinglycosid

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee